Reactiv8
Payments companies reported to CMS as associated with Reactiv8. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Reactiv8, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Reactiv8
These are the largest totals companies reported as associated with Reactiv8. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Christopher Gilligan | Boston, MA | Emergency Medicine | $617,780.39 |
| Frank Schwab | New York, NY | Orthopaedic Surgery of The Spine | $480,945.66 |
| Robert Heros | Tualatin, OR | Pain Medicine (Physical Medicine & Rehabilitation) | $160,121.34 |
| Meredith Langhorst | Fishers, IN | Pain Medicine | $111,651.96 |
| Kiran Patel | New York, NY | Anesthesiology | $84,289.75 |
| Justin Bundy | Augusta, GA | Orthopaedic Surgery of The Spine | $53,738.66 |
| Rebecca Sanders | Joplin, MO | Interventional Pain Medicine | $53,692.89 |
| Anthony Giuffrida | Fort Lauderdale, FL | Physical Medicine & Rehabilitation | $47,215.65 |
| Gabriel Pagani-Estevez | Rochester, MN | Interventional Pain Medicine | $41,266.86 |
| Christopher Paul | Birmingham, AL | Pain Medicine (Anesthesiology) | $41,186.30 |
Prescribed Reactiv8?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.